STOCK ELYSE (Chief Medical Officer) exercised options at BIOHAVEN PHARMACEUTICAL HOLDING CO LTD.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 1/12/2022ACC: 0001562180-22-000439
Officer· Chief Medical Officer
Since Aug 2019
+1.87K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
1.87K acquired
Non-Derivative Transactions1
Common Shares
Indirect
Shares
+937.00
Price / share
—
Trade value
—
% of position
21.1%
1/10/2022
4.44K→5.37K
Total
Net shares
+937.00
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Indirect | 1/10/2022 | M · Option Exercise | +937.00 | — | — | 21.1% | 4.44K | 5.37K |
| Total | +937.00 | $0.00 | ||||||
Derivative Transactions1
Restricted Share Unit Award
Indirect
Converts to
Common Shares
937.00 shares
Shares
+937.00
Strike price
Held after
938.00
Exercisable
—
1/10/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Share Unit Award Indirect | Common Shares937.00 shares | 1/10/2022 | M · Option Exercise | +937.00 | — | 938.00 |
Non-Derivative Holdings (Post-Transaction)1
Common Shares
DirectShares owned11.09K
Total
11.09K direct11.09K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Shares | 11.09K | Direct |
| Total | 11.09K | 11.09K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported